HomeCompareIUSDF vs MRK

IUSDF vs MRK: Dividend Comparison 2026

IUSDF yields 3.09% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.5K in total portfolio value
10 years
IUSDF
IUSDF
● Live price
3.09%
Share price
$14.00
Annual div
$0.43
5Y div CAGR
-23.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$23.15
Full IUSDF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — IUSDF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIUSDFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IUSDF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IUSDF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IUSDF
Annual income on $10K today (after 15% tax)
$262.81/yr
After 10yr DRIP, annual income (after tax)
$19.68/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,577.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IUSDF + MRK for your $10,000?

IUSDF: 50%MRK: 50%
100% MRK50/50100% IUSDF
Portfolio after 10yr
$39.5K
Annual income
$5,068.46/yr
Blended yield
12.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IUSDF
No analyst data
Altman Z
5.9
Piotroski
7/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IUSDF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIUSDFMRK
Forward yield3.09%2.81%
Annual dividend / share$0.43$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-23.4%32.7%
Portfolio after 10y$21.2K$57.7K
Annual income after 10y$23.15$10,113.78
Total dividends collected$975.00$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IUSDF vs MRK ($10,000, DRIP)

YearIUSDF PortfolioIUSDF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,937$236.84$11,213$373.04$276.00MRK
2$11,888$185.44$12,667$512.06$779.00MRK
3$12,864$144.30$14,439$708.14$1.6KMRK
4$13,877$111.78$16,640$988.16$2.8KMRK
5$14,934$86.32$19,432$1,394.07$4.5KMRK
6$16,046$66.51$23,057$1,992.90$7.0KMRK
7$17,221$51.16$27,889$2,894.79$10.7KMRK
8$18,465$39.30$34,518$4,286.29$16.1KMRK
9$19,788$30.17$43,912$6,494.35$24.1KMRK
10$21,196$23.15$57,714$10,113.78$36.5KMRK

IUSDF vs MRK: Complete Analysis 2026

IUSDFStock

AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally. It offers scientific instruments comprising temperature/humidity control and measuring/surveying instruments, as well as universal products used for cooling, heating, mixing, absorption, pressurization, and conveyance; microscopes, glass slides, and tissue culture products for biotechnology; magnifying glasses indispensable for precision work, plus filters, and dispensing devices required for analysis technology; equipment indispensable for research facilities, such as experimental platforms, fume hoods, and pharmaceutical depositories, as well as storage equipment, wagons, laboratory chairs, and conveyance equipment; containers required for storage or preservation of samples, reagents, materials, and others; glass or plastic beakers, flask indispensables, hoses, tubes, and joints; tapes and labels; and timers, packaging machines, tools, office supplies, and other equipment for laboratories. The company also provides industrial instruments, such as dehumidifying storage products; equipment for organization, conveyance, etc.; equipment for sterilization/disinfecting and cleaning, including ultrasonic cleaners for washing/drying, detergents, and drying tools; glasses, masks, and gloves; and tools and containers used in clean rooms, as well as dust-proof and anti-static products comprising clean room clothes and mats indispensable. In addition, it offers hospital/nursing instruments, such as white gowns, masks, and gloves; rack systems to be installed in nursing stations; various products, supplies, and equipment required for hospital nursing or care; and sterilizers and sterilization lockers, as well as care cars and beds, and bathing and sanitary products. The company was founded in 1933 and is headquartered in Osaka, Japan.

Full IUSDF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IUSDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IUSDF vs SCHDIUSDF vs JEPIIUSDF vs OIUSDF vs KOIUSDF vs MAINIUSDF vs JNJIUSDF vs ABBVIUSDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.